Pharmacology
 |
|
14 may 2019 17:03:05 |
| CYP2C19 genotype, physician prescribing pattern, and risk for long QT on serotonin selective reuptake inhibitors (Pharmacogenomics) |
|
Tweet Pharmacogenomics, Volume 20, Issue 5, Page 343-351, April 2019. |
| 59 viewsCategory: Genomics, Pharmacology |
 VMAT2 gene (SLC18A2) variants associated with a greater risk for developing opioid dependence (Pharmacogenomics)Genetics and adverse events with irinotecan treatment: what do we know? (Pharmacogenomics) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
